Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Report uncovers the barriers to disease control
IFAH calls for a joint approach to overcome key issues

Joint efforts are needed to minimise the risks of emerging and re-emerging animals diseases, according to a report by the International Federation for Animal Health (IFAH).

The report, titled "Emerging and re-emerging animal diseases - barriers to disease control", launched at a stakeholder event held at the Royal Society in London.

It concludes that further investment is needed in education, research and institutional effectiveness - both locally and globally - in order to reduce the risks to animal and human health and encourage long-term economic growth.

Three dominant barriers to effective disease control are examined in the report - barriers to research and development; barriers to commercialisation; and barriers to the use of veterinary medicines.

IFAH commissioned global analysis and advisory firm, Oxford Analytica, who were supported by a group of independent experts in animal health, to examine these barriers.

Key barriers to research were the high cost of developing medicines and a lack of veterinary experts to carry out diagnostic controls, leading to inefficiencies in responses to disease outbreaks. Additionally, the development of vaccines was found to be hindered by the constantly changing nature of virus strains.

According to the report, overly burdensome regulations and lack of streamlined approval processes cause delays and increase costs of bringing veterinary medicines to market.

Furthermore, the use of veterinary medicines was found to be facing a lack of government support and logistical problems in the distribution and availability of the medicines.

Mike McGowan, IFAH's acting executive director and programme chair, noted that rapid increases in the human population and wealth have led to unprecedented demand for livestock products. The risk of further serious epidemics will grow, he says, as pathogens evolve and mutate.

Given that 75 per cent of emerging animal diseases are zoonotic, Mr McGowan stressed that this will impact both animal and human health.

"IFAH commissioned this white paper as a launch point for wider collaborative discussions with international stakeholders on what future efforts would be required to overcome barriers that limit our ability to control emerging and re-emerging diseases," Mr McGowan said.

"Regulatory harmonisation, empowering veterinarians, public-private partnerships and cooperation between the animal and human health sectors are vital to ensure that we can respond to and control disease outbreaks."

The full report can be downloaded here.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.